Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus

Journal of the American College of Cardiology

Volumn 52, Issue 22, 2008, Pages 1793-1799

  Rijzewijk, Luuk J ^a   van der Meer, Rutger W ^b   Smit, Johannes W A ^b   Diamant, Michaela ^a   Bax, Jeroen J ^b   Hammer, Sebastiaan ^b   Romijn, Johannes A ^b   de Roos, Albert ^b   Lamb, Hildo J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

diabetes mellitus; diastolic function; magnetic resonance imaging; myocardial lipids; spectroscopy

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DISEASE COURSE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING; HEART MUSCLE STEATOSIS; HEART RATE; HUMAN; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; MALE; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STEATOSIS; SYSTOLE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIASTOLE; FEMALE; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; TRIGLYCERIDES; VENTRICULAR FUNCTION, LEFT;

EID: 55949119360     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.062     Document Type: Article

References (33)

1. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract 31 Suppl (1996) S3-S13
2. Taegtmeyer H., McNulty P., and Young M.E. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105 (2002) 1727-1733
3. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14 (2003) 281-287
4. Sharma S., Adrogue J.V., Golfman L., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18 (2004) 1692-1700
5. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
6. Young M.E., McNulty P., and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105 (2002) 1861-1870
7. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 (2000) 1784-1789
8. Ouwens D.M., Boer C., Fodor M., et al. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia 48 (2005) 1229-1237
9. Perseghin G., Petersen K., and Shulman G.I. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 27 Suppl 3 (2003) S6-S11
10. McGavock J.M., Lingvay I., Zib I., et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116 (2007) 1170-1175
11. van der Meer R.W., Hammer S., Smit J.W., et al. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56 (2007) 2849-2853
12. D'Eon T.M., Souza S.C., Aronovitz M., et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280 (2005) 35983-35991
13. Stahlberg N., Rico-Bautista E., Fisher R.M., et al. Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 145 (2004) 1972-1979
14. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
15. Ewing D.J., Martyn C.N., Young R.J., et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 (1985) 491-498
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
17. van der Meer R.W., Doornbos J., Kozerke S., et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245 (2007) 251-257
18. Naressi A., Couturier C., Devos J.M., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 12 (2001) 141-152
19. Paelinck B.P., de Roos A., Bax J.J., et al. Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45 (2005) 1109-1116
20. Diamant M., Lamb H.J., van de Ree M.A., et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 1495-1501
21. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961
22. Balschi J.A., Hai J.O., Wolkowicz P.E., et al. 1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids. J Mol Cell Cardiol 29 (1997) 471-480
23. Straeter-Knowlen I.M., Evanochko W.T., den Hollander J.A., et al. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. Circulation 93 (1996) 1464-1470
24. Torriani M., Thomas B.J., Barlow R.B., et al. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol 100 (2006) 609-614
25. Badimon J.J., Badimon L., and Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 85 (1990) 1234-1241
26. Listenberger L.L., Han X., Lewis S.E., et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100 (2003) 3077-3082
27. Chiu H.C., Kovacs A., Ford D.A., et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107 (2001) 813-822
28. Palmieri V., Bella J.N., DeQuattro V., et al. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study). Am J Cardiol 84 (1999) 558-562
29. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150
30. Poornima I.G., Parikh P., and Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98 (2006) 596-605
31. Targher G., Bertolini L., Poli F., et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54 (2005) 3541-3546
32. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
33. Zib I., Jacob A.N., Lingvay I., et al. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med 55 (2007) 230-236